Background/Aims: The well-organized study to support that increased cholelithiasis and bile duct dilatation can occur after gastrectomy has not been reported. The aim of this study was to determine the incidence of cholelithiasis and the degree of common bile duct (CBD) dilatation in patients undergoing subtotal gastrectomy, compared to those undergoing endoscopic treatment for gastric cancer. Methods: Patients who diagnosed with gastric cancer and received treatment at six academic referral centers were investigated for the incidence and time of cholelithiasis and the degree of CBD dilatation after treatment by analysis of 5-year follow-up CTs. The operation group underwent subtotal gastrectomy without vagotomy, while in the control group endoscopic treatment was administered for gastric cancer. Results: A total of 802 patients were enrolled in 5-year analysis (735 patients in the operation group and 67 patients in the control group). Cholelithiasis occurred in 47 patients (6.39%) in the operation group and 3 patients (4.48%) in the control group (p=0.7909). The incidences of cholelithiasis were 4.28% in Billoth-I and 7.89% in Billoth-II (p=0.0487). The diameter of proximal CBD and distal CBD increased by 1.11 mm and 1.41 mm, respectively, in the operation group, compared to 0.4 mm and 0.38 mm, respectively, in the control group (p＜0.05). Patients with increased CBD dilatation more than 5 mm showed statistically significant increases in alkaline phosphatase and gamma-glutamyltransferase. Conclusions: The incidence of cholelithiasis was not increased due to subtotal gastrectomy without vagotomy, but the incidence was higher after Billoth-II compared to Billoth-I. In addition, significant change in the CBD diameter was observed after subtotal gastrectomy. (Korean J Gastroenterol 2015;66:33-40) 
INTRODUCTION
Widespread use of cancer screening programs has recently led to a continuous increase in the diagnostic rate of early gastric cancer. Improved outcome after gastrectomy has also contributed to long-term survival. However, longterm survival can also cause delayed complications after gastrectomy. Above all, biliary disease including cholelithiasis, caused by anatomical change after gastrectomy, is difficult to manage endoscopically with ERCP, and adhesion at the surgical site also makes surgical treatment more dangerous. In addition, clinicians frequently encounter patients with asymptomatic bile duct dilatation after gastrectomy and are faced with difficulty in choosing evaluation methods.
One of the most important hypotheses for increasing incidence rate of cholelithiasis after gastrectomy is injury to the vagus nerve, which coordinates the motion of the gallbladder (GB). Vagotomy during gastrectomy can cause sphincter of Oddi dysfunction, delayed bile circulation, increasing GB intraluminal pressure, and adverse hormonal effects. Therefore, it can be expected that gastrectomy including vagotomy may cause cholelithiasis and bile duct dilatation. [1] [2] [3] [4] [5] [6] In the past, vagotomy was almost inevitable due to lymph node dissection when performing gastrectomy in patients with gastric cancer, which led to the hypothesis that cholelithiasis is increased after gastrectomy, although the number of reports is limited. [7] [8] [9] It would be necessary to determine whether the incidence of cholelithiasis has actually increased after surgery, in addition to its complications and clinical characteristics. No systematic study in a large sample, or any study investigating the incidences of cholelithiasis and bile duct dilatation after subtotal gastrectomy without vagotomy has been reported.
In the situation without vagotomy, might the incidence of cholelithiasis also be increased? Some reports have suggested that the risk of cholelithiasis differed depending on the method of gastrectomy, but the results varied among a few studies. [10] [11] [12] Exclusion of the duodenum during reconstruction or non-physiologic tract reconstruction, leading to changes in the secretion of cholecystokinin, can be a potential risk of cholelithiasis. 13 The chyme would pass directly to the jejunum, and then cause low cholecystokinin secretion, GB dyskinesia, and cholestasis. However, studies on cholecystokinin level before or after meals in patients with those situations did not support that theory. 14, 15 The aim of this study was to evaluate the incidence of cholelithiasis and the degree of CBD dilatation in patients diagnosed with gastric cancer who underwent subtotal gastrectomy without vagotomy using 5-year follow-up abdominal CT.
SUBJECTS AND METHODS

Study population
Patients diagnosed with gastric cancer at six academic re- 735 were included the operation group and 67 were included in the control group. Retrospective cohort analysis was performed for these patients to determine the incidence of cholelithiasis and the change of bile duct diameter.
Methods
1) Biological and clinical parameters
Patients who met the above mentioned inclusion/exclusion criteria were investigated for the incidence and time were subdivided into subtotal gastrectomy and gastroduodenostomy (Billoth-I) group or subtotal gastrectomy and gas- Values are presented as mean±SD or n (%). 
2) Measurement of CBD diameter
Differentiating the CBD from the common hepatic duct can be difficult due to variability of location, or sometimes invisibility of the cystic duct. Therefore, CBD dilatation was measured by separating the proximal part and the distal part.
The diameter immediately distal to the porta hepatis was measured for the proximal CBD (P-CBD), while the diameter visible in the head of the pancreas was measured for the distal CBD (D-CBD) ( Fig. 1) . Considering the possibility of inaccuracy when measuring long axis diameter, due to an often oblique bile duct on axial CT images, the diameter was measured on short axis view.
3) End point
The primary endpoint of this study was to evaluate the incidence and development time of cholelithiasis and choledocholithiasis after subtotal gastrectomy for stomach cancer. The secondary endpoint was to evaluate the degree of CBD dilatation.
Statistical analysis
Analysis of baseline characteristics and incidence was performed using independent-samples Student ttest and 
RESULTS
Baseline characteristics
A total of 802 patients were enrolled in 5-year analysis (735 patients in the operation group and 67 patients in the control group). Baseline characteristics of the operation group and the control group are shown in Table 1 . No statistically significant difference was observed between the two groups, although patients in the operation group tended to be younger.
Incidence of cholelithiasis
Cholelithiasis occurred in 47 patients (6.39%) in the operation group and 3 patients (4.48%) in the control group. But, there was no statistical difference between two groups (p=0.7909) ( Table 2 ). Interestingly, there was no occurrence of choledocholithiasis in any patients in either group.
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Incidence of cholelithiasis by operation method
Frequency and extent of CBD dilatation
Five years after the operations, P-CBD and D-CBD diameters were dilated by less than 5 mm in more than 95% of the total 802 patients (Table 5 ). Mean proximal CBD diameter Changes in distal CBD diameters (1.41 mm in the operation group vs. 0.38 mm in the control group) also showed statistical significance (p=0.0335) ( Table 6) .
Results of the logistic analysis showed that reconstruction method did not have a statistically significant effect on proximal CBD dilatation (OR=0.417). In contrast, with distal CBD dilatation, Billroth-I had less effect on CBD dilatation (OR= 0.046).
Factors affecting CBD dilatation
When adjusted for confounding factors, age was the statistically significant prognostic factor affecting development of proximal CBD dilatation (OR=1.034 and p=0.0237, respectively). Gender and body weight were not significant prognostic factors affecting bile duct dilatation. Values are presented as n (%). D-CBD, distal common bile duct; P-CBD, proximal common bile duct. Values are presented as mean±SD or n (%). D-CBD, distal common bile duct; P-CBD, proximal common bile duct. Delta diameter change was defined as average diameter at initial diagnosis minus average diameter after 5 years follow up. 
Association between laboratory findings and the incidences of cholelithiasis and CBD dilatation
Post-operative assessment of 5-year changes in AST, ALT, total bilirubin, ALP, and GGT to determine the association be- (Table 7) .
DISCUSSION
Vagotomy, which is inevitable during gastrectomy, is associated with increased incidence of cholelithiasis and increased bile duct diameter afterwards, although the pathophysiology is uncertain. [16] [17] [18] Old studies indicate that GB motor dysfunction due to hypomotility or hypermotility, bile acid storage in the small bowel, GB inflammation, and enterohepatic bile circulation commonly contribute to development of pigment stone, and that development of GB stones after gastrectomy is caused by GB hypomotility. [19] [20] [21] [22] However, there are also disputes over such hypotheses, including re-ports suggesting that the incidence of cholelithiasis does not increase, because vagus nerve injury is not the main cause of GB hypomotility. [23] [24] [25] [26] There were also reports that not only amputated and injured vagus nerve has a fundamental effect on GB motor, but sphincter of Oddi dysfunction through cholecystokinin secretion control also causes GB hypomotility indirectly. 27, 28 In addition, cholecystokinin mainly causes contraction of the GB indirectly through vagus nerve, but it works in part on the muscle directly. 29 Therefore, we aimed at determining the effect of gastrectomy without vagotomy on cholelithiasis and CBD dilatation. difference. It should be noted that the incidence of cholelithiasis after gastrectomy was considerably higher than the prevalence of cholelithiasis detected during health examinations in South Korea (2.3-4.9%). 30 As it was a retrospective study, only patients who underwent gastric cancer treatment and annual follow-up abdominal CTs were included. It is possible that inclusion of patients without follow-up study in the analysis or use of abdominal sonography would have resulted in a greater increase in prevalence. In most cases the CBD was dilated by less than 5 mm, which could be associated with the normal aging process due to the passage of time. However, the diameters measured 5 years after treatment were higher with statistical significance after subtotal gastrectomy compared to the control group. This result suggests that not only vagus nerve but also other various factors affect cholelithiasis and CBD dilatation after gastric surgery.
In most cases development of cholelithiasis occurs after gastrectomy early after surgery. 2, 31 In our study, cholelithiasis occurred in 27.6% (13/47) of patients within 6 months, This study is relevant in that it found incidence and features of cholelithiasis after subtotal gastrectomy, objective difference of CBD dilatation by operation method, and their association with predictors and laboratory findings through a multi-center study. Limitations of this study include being a retrospective cohort analysis study; possible underestimation of actual cholelithiasis occurrence by use of CT, instead of sonography, for identification of cholelithiasis; relatively small size of the control group (because ESD was not widely used during the study period and because there were few patients who underwent follow-up CT until 5 years after treatment); possible omission of vagotomy performance on medical record; lack of investigation on comorbidity; and lack of analysis of gastric cancer staging (the radical lymph node dissection might be an another risk factor for cholelithiasis).
In conclusion, subtotal gastrectomy itself for management of gastric cancer did not increase the incidence of cholelithiasis, but there was a difference depending on reconstruction method such that Billoth-II was associated with higher incidence than Billoth-I. In addition, significant change in the CBD diameter was observed after subtotal gastrectomy.
Furthermore, CBD dilatation after gastrectomy can be associated with increased GGT level. Conduct of a large-scale, prospective study, involving more long-term follow-up, will be required in the future.
